Natalizumab

ATC L04AG03 · 11 markets · 29 records

Natalizumab 11 markets · 29 records Forms

AU 7 records · 5 strengths

300 mg/15 mLinjectionTYSABRI also in GB·US·SG
300 mginjectionTYRUKO natalizumab 300 mg/15 mL concentrate for infusion vial+1TYSABRI natalizumab 300mg/15 mL concentrate for infusion vial also in ES·TW unknown
150 mg/1 mLinjectionTYSABRI also in GB
150 mginjectionTYSABRI natalizumab 150 mg/1 mL injection solution pre-filled syringe also in ES unknown

2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名TYRUKO ×2TYSABRI ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

GB 3 records · 2 strengths

300 mg/15 mLinjectionTyruko 300mg/15ml concentrate for solution for infusion vials+1Tysabri 300mg/15ml concentrate for solution for infusion vials also in AU·US·SG
150 mg/1 mLinjectionTysabri 150mg/1ml solution for injection pre-filled syringes also in AU

ES 3 records · 3 strengths

300 mginjectionTYRUKO also in AU·TW
150 mginjectionTYSABRI PRECARGADA also in AU
20 mginjectionTYSABRI

MX 3 records · 1 strengths

3 records · 0 manufacturers 3 registros · 0 fabricantes 3 个记录 · 0 个厂家 3 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名TYRUKO ×2TYSABRI ×2TYSABRI SC ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

EU 3 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

3 records · 0 manufacturers 3 registros · 0 fabricantes 3 个记录 · 0 个厂家 3 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名Natalizumab Elan Pharma ×1TYRUKO ×2TYSABRI ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

US 2 records · 1 strengths

300 mg/15 mLinjectionTYRUKO+1TYSABRI also in AU·GB·SG

CA 2 records · 1 strengths

20 mg/1 mLliquidTYRUKO+1TYSABRI

FR 2 records · 1 strengths

20 mg/1 mLinjectionTYRUKO 300 mg, solution à diluer pour perfusion+1TYSABRI 300 mg, solution à diluer pour perfusion

SG 1 records · 1 strengths

300 mg/15 mLinjectionTysabri concentrate for solution for infusion 300mg also in AU·GB·US

TW 1 records · 1 strengths

300 mginjectionTysabri concentrate for solution for infusion 300mg+1泰吉利濃縮靜脈輸注液 300 毫克 also in AU·ES

HK 1 records · 1 strengths

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名Tysabri concentrate for solution for infusion 300mg ×3

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

Side-by-side table

Strength / form / release	US	GB	CA	AU	SG	ES	MX	TW	HK	EU	FR
300 mg/15 mL injection	TYRUKO TYSABRI	Tyruko 300mg/15ml concentrate for solution for infusion vials Tysabri 300mg/15ml concentrate for solution for infusion vials	not recorded	TYSABRI	Tysabri concentrate for solution for infusion 300mg	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
300 mg injection	not recorded	not recorded	not recorded	TYRUKO natalizumab 300 mg/15 mL concentrate for infusion vial TYSABRI natalizumab 300mg/15 mL concentrate for infusion vial	not recorded	TYRUKO	not recorded	Tysabri concentrate for solution for infusion 300mg 泰吉利濃縮靜脈輸注液 300 毫克	not recorded	not recorded	not recorded
20 mg/1 mL liquid	not recorded	not recorded	TYRUKO TYSABRI	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
150 mg/1 mL injection	not recorded	Tysabri 150mg/1ml solution for injection pre-filled syringes	not recorded	TYSABRI	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
150 mg injection	not recorded	not recorded	not recorded	TYSABRI natalizumab 150 mg/1 mL injection solution pre-filled syringe	not recorded	TYSABRI PRECARGADA	not recorded	not recorded	not recorded	not recorded	not recorded
20 mg/1 mL injection	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	TYRUKO 300 mg, solution à diluer pour perfusion TYSABRI 300 mg, solution à diluer pour perfusion
20 mg injection	not recorded	not recorded	not recorded	not recorded	not recorded	TYSABRI	not recorded	not recorded	not recorded	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	TYRUKO TYSABRI	not recorded	not recorded	not recorded	not recorded	Tysabri concentrate for solution for infusion 300mg	Natalizumab Elan Pharma TYRUKO TYSABRI	not recorded
not disclosed liquid	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	TYRUKO TYSABRI TYSABRI SC	not recorded	not recorded	not recorded	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

3 more strength/form rows are recorded only in CA · MX · FR and are not shown in this table. Hay 3 filas de concentración/forma registradas solo en CA · MX · FR que no se muestran en esta tabla. 另有 3 个规格/剂型仅在 CA · MX · FR 有记录（未在本表显示）。另有 3 個規格/劑型僅在 CA · MX · FR 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.